Last reviewed · How we verify

NCT07374679

Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease

Not yet recruiting Last updated 29 January 2026
What this trial tests

trial in Rotator Cuff Disease in 21 participants. Not yet recruiting.

Timeline
26 January 2026
Primary endpoint
30 May 2031
30 January 2032

Quick facts

Lead sponsorSeoul National University Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment21
Start date26 January 2026
Primary completion30 May 2031
Estimated completion30 January 2032
Sites1 location across South Korea

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

19 and older, any sex, with Rotator Cuff Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients with Rotator Cuff Disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07374679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing